JOH306-20 Using Ibrutinib in Earlier Lines of Treatment Results in Better Outcomes for Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma imbruvica® (ibrutinib) capsule – Riassunto Delle Caratteristiche Del Prodotto Using Ibrutinib in Earlier Lines of Treatment Results in Better Outcomes for Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Access Document imbruvica® (ibrutinib) capsule – Riassunto Delle Caratteristiche Del Prodotto Access Document